How to Help Your Patients Save Money on Spritam: A Provider's Guide to Savings Programs

Cost is one of the most common drivers of medication non-adherence in epilepsy — and for a drug like Spritam, where the retail cash price exceeds $600 per month, this is a real clinical problem. A patient who can't afford their anti-seizure medication and skips doses — or doesn't fill it at all — faces serious safety consequences. This guide gives providers a practical overview of every savings mechanism available for Spritam in 2026, so you can proactively connect your patients with relief before cost becomes a barrier.

Understanding the Spritam Cost Landscape

Providers need to understand the cost environment their patients are navigating:

Brand Spritam retail (cash) price: ~$639–$690 for a 60-tablet (30-day) supply, regardless of strength (250 mg, 500 mg, 750 mg, 1000 mg)

Commercial insurance copay (if covered): Highly variable by plan — Tier 2 coverage may mean $30–$80 copays; specialty tier may mean $100–$200+ before savings programs apply

Standard generic levetiracetam IR tablets: As low as $6–$7/month with GoodRx or SingleCare coupons — a 98%+ cost difference compared to brand Spritam

The enormous price difference between Spritam and generic levetiracetam makes the first prescribing decision — whether a patient actually needs the 3D-printed formulation — a meaningful cost-of-care decision. Spritam is the right choice for patients with genuine swallowing difficulties, tube feeding dependence, or documented inability to take conventional tablets. For patients who can swallow standard tablets, prescribing generic levetiracetam IR is both clinically equivalent and dramatically more affordable.

The SPRITAM Serve Savings Program: What Providers Need to Know

The SPRITAM Serve program, administered by Prasco LLC, is the most powerful savings mechanism for eligible patients. It consists of three separate offerings:

A. Retail E-Voucher Program

Commercially insured patients (plan covers Spritam): Copay as low as $10 for a 30-day supply. Max benefit: $390 per 30-day supply.

Commercially insured patients (plan does NOT cover Spritam): Cost as low as $75 per month. Max annual benefit: $2,000. Applied in real time at point of dispensing — no paper coupons needed.

B. SPRITAM Serve Coupon (Highest Annual Benefit)

Commercially insured (plan covers Spritam): Copay as low as $10/month; max annual benefit $5,000; up to 12 fills per year.

Uninsured or uncovered patients: Cost as low as $10/month; max annual benefit $2,500. This is the highest-value option for most commercially insured patients.

C. Blink Health Specialty Pharmacy Program (Includes Home Delivery)

All commercially insured and uninsured patients: Copay/cost as low as $10 (insured) or $75 (uninsured); max annual benefit $5,000. Includes home delivery and PA support.

Program eligibility restrictions: The SPRITAM Serve program is NOT available to patients covered by Medicare, Medicaid, TRICARE, VA, DoD, or any other federal/state government program. Patients are limited to one program offering. Contact: 844-SPRITAM (844-777-4826).

How to Integrate Savings Programs Into Your Practice Workflow

The most effective approach is to address cost proactively at the time of prescribing — not reactively when a patient calls to report they can't afford a refill:

At the initial Spritam prescription, ask about insurance status and briefly explain the SPRITAM Serve program. Give the patient the phone number (844-777-4826) before they leave.

For Blink Health: note that they can handle PA support — this reduces work for your office and gets the patient's prescription filled faster.

Train your medical assistant or care coordinator to ask about cost barriers at every visit. Patients often don't volunteer that they're skipping doses because of cost.

For Medicare/Medicaid patients: direct them to explore whether the authorized generic (same Aprecia product, Prasco label) has different formulary placement on their plan, and refer to NeedyMeds.org or RxAssist.org for assistance programs.

For Medicare and Medicaid Patients: Alternative Strategies

Since SPRITAM Serve is not available to government insurance patients, these patients require a different approach:

Levetiracetam oral solution (100 mg/mL generic): Widely covered by Medicare and Medicaid at low cost. If the clinical need for Spritam is primarily about ease of swallowing, the oral solution meets the same need at dramatically lower cost.

Standard generic levetiracetam IR tablets: For patients who can swallow tablets, generic Keppra is universally covered by Medicare and Medicaid at Tier 1 (preferred generic) cost — typically $0–$10 copay.

Patient assistance programs: For patients truly requiring brand Spritam who cannot afford it, UCB Pharmaceuticals (1-800-UCB-5555) has patient assistance options. NeedyMeds.org and RxAssist.org list all available programs and eligibility criteria.

Prior Authorization: Reduce Delay With Proactive Documentation

Some commercial payers require prior authorization for Spritam. PA approval is much faster and more likely when clinical documentation is complete at the time of submission. Key documentation to have ready:

Diagnosis code (epilepsy type) and ICD-10 code

Clinical rationale for Spritam specifically: dysphagia diagnosis (R13.x), neurological condition affecting swallowing, pediatric age and weight, tube feeding dependence (Z43.1/Z43.2), or documented failure/intolerance to conventional tablet levetiracetam

Documentation of seizure history and type

Prior medications tried and reason for change (if applicable)

Quick Reference: Savings Program Summary

Commercially insured, plan covers Spritam: SPRITAM Serve Coupon → $10/month, max $5,000/year

Commercially insured, plan does NOT cover Spritam: SPRITAM Serve Coupon → $10/month, max $2,500/year

Uninsured: SPRITAM Serve Coupon → $10/month (max $2,500/year)

Medicare/Medicaid: Not eligible for SPRITAM Serve; transition to generic levetiracetam oral solution or IR tablets, or explore UCB assistance

All patients (generic alternative): Generic levetiracetam IR tablets → $6–$7/month with GoodRx; generic oral solution also widely available at low cost

For availability support, see: Spritam: What Providers Need to Know in 2026. Or visit medfinder for Providers to help patients locate Spritam at pharmacies near them.